AstraZeneca plc (AZN) Ordinary US$0.25
187.00p
(2.44%)
- Add to watchlist
- Create an alert
- This stock can be held in a
187.00p
(2.44%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
187.00p
(2.44%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
7,550.00p
7,597.00p
7,948.00p
£98.03 bn
7,659.00p
7,459.00p
5,322.00p
28.91
2.00p (0.03%) Previous:
2.00p
470,485
2.88%
300
Performance
| 1 week 1W | 0.62% | 1 year 1Y | 39.76% |
|---|---|---|---|
| 1 month 1M | 1.91% | 2 years 2Y | 54.07% |
| 3 months 3M | 4.87% | 3 years 3Y | 81.71% |
| 6 months 6M | 10.92% | 5 years 5Y | 63.32% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Fundamental data
| Year ending: | 31/12/2018 | 31/12/2017 |
|---|---|---|
| Revenue ($m) | 22,090.00 | 22,465.00 |
| Profit before tax ($m) | 1,993.00 | 2,227.00 |
| Adjusted EPS (¢): | 346.00 | 428.00 |
| P/E ratio | 22.20 | 15.60 |
| PEG | n/a | n/a |
| EPS growth (%) | (19.00) | (1.00) |
Values are quoted in the stock's local currency: US dollar
All fundamental dataRecent dividends paid or declared by AstraZeneca plc:
| Type | Ex-div date | Payment date | Amount |
|---|---|---|---|
| 1st interim | 08/08/2019 | 09/09/2019 | 90.00¢ |
| 2nd interim | 28/02/2019 | 27/03/2019 | 190.00¢ |
| 1st interim | 09/08/2018 | 10/09/2018 | 90.00¢ |
| 2nd interim | 15/02/2018 | 19/03/2018 | 190.00¢ |
| 1st interim | 10/08/2017 | 11/09/2017 | 90.00¢ |
This data is provided by Digital Look. HL accepts no responsibility for its accuracy and you should independently check data before making any investment decision.
Full dividend historyFive years' total annual AstraZeneca plc dividends:
| Financial year end |
Dividend yield |
Dividend cover |
Total dividend paid |
|---|---|---|---|
| 31/12/2018 | 3.60% | 1.24 | $2.80 |
| 31/12/2017 | 4.20% | 1.53 | $2.80 |
| 31/12/2016 | 4.80% | 1.54 | $2.80 |
| 31/12/2015 | 4.60% | 1.52 | $2.80 |
| 31/12/2014 | 4.70% | 1.53 | $2.80 |
All dividend data is calculated excluding any special dividends. Historical dividends may be adjusted to reflect any subsequent rights issues and corporate actions.
Full dividend historyReady to invest?
To buy shares in , you'll need to have an account. Try our handy filter to explore the different options.
Ready to take your first step?
To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.
Important Documents
There are no documents available for this stock.
Broker forecasts
-
Strong Sell
(1 of 13) -
Sell
(1 of 13) -
Neutral
(2 of 13) -
Buy
(1 of 13) -
Strong Buy
(8 of 13)
This is not a recommendation, it represents the consensus view of a basket of brokers. If fewer than 5 brokers it may not be a valid consensus. HL might not concur and takes no responsibility.
Full broker forecasts-
Astra reports positive results from stroke, gastric cancer trials
27 January 2020 09:24
-
AstraZeneca sells hypertension drug rights; Ends Allergan deal
27 January 2020 07:53
-
Wednesday broker round-up
22 January 2020 12:52
-
Enhertu Phase II trial met primary endpoint
27 January 2020 07:00
-
Brilinta met primary endpoint in stroke trial
27 January 2020 07:00
-
AstraZeneca divests hypertension medicines
27 January 2020 07:00
| Time / date Time | Buy / sell Type | Volume | Price | Value |
|---|
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled ‘N/A’.
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.